Complete at least 3 months of therapy with Wegovy at a stable maintenance dose
Int J Cell Biol
Hellstrom PM, Hein J, Bytzer P, Bjornsson E, Kristensen J, Schambye H (2009) Clinical trial: the glucagon-like peptide-1 analogue ROSE-010 for management of acute pain in patients with irritable bowel syndrome: a randomized, placebo-controlled, double-blind study
Hector Perez, a board-certified bariatric surgeon, believes the interest in these probiotics could also be "an aftereffect of the success of GLP-1 drugs, which have now brought public focus on gut microbiome and weight loss." He notes that more people are beginning to connect that metabolism goes beyond calories and may be shaped by gut health
These medications not only help with weight loss and blood sugar control but also reduce cardiovascular risks, including heart attacks and strokes, especially in high-risk patients
There are no clinical trials on this patch format, no data testing this ingredient combo, and no human studies showing increased GLP-1 levels from this approach